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1. Introduction 
Colonic pseudo-obstruction is a condition of distention of colon with signs and symptoms of 
colonic obstruction in the absence of an actual mechanical cause of obstruction. It is a poorly 
understood disease that is characterized by functional large bowel obstruction.  
Intestinal pseudo-obstruction was described in 1938 by the German surgeon W. Weiss who 
reported mega-duodenum in 6 persons in 3 generations of a German family and described it 
as an inherited subset of intestinal pseudo-obstruction[2]. A similar condition of pseudo-
obstruction of intestine was described by Ingelfinger in 1943. Colonic pseudo-obstruction, 
however, was first described by Sir William Heneage Ogilvie in 1948 and named after him 
as “Ogilvie’s Syndrome”. His description was based on the findings of two patients who 
had non-mechanical obstruction due to retroperitoneal involvement of the celiac plexus by 
malignancy[1]. J. Dunlop in 1949 described a similar condition in men aged 56, 58, and 66 
years where large bowel colic was the predominant symptom accompanied by constipation, 
abdominal distension, and progressive loss of weight, but with no evidence of mechanical 
obstruction to the intestinal flow[3]. In 1958, Dudley et al used the term pseudo-obstruction 
to describe the clinical appearance of a mechanical obstruction with no evidence of organic 
disease during laparotomy[4].  
Ogilvie’s syndrome commonly occurs in patients who are critically ill, have electrolyte 
imbalance, or on anticholinergic medications. If left untreated, life threatening complications 
like bowel ischemia or perforation may occur in up to 15% of cases with a mortality of  
50%[5]. 
2. Epidemiology  
The prevalence of colonic pseudo-obstruction is difficult to know but the disorder nearly 
always occurs in hospitalized patients. It is commonly found in patients undergoing major 
surgeries, patients with advanced malignancies, and in spinal trauma patients. It is usually 
associated with surgical procedures which require prolonged bed rest. As such, the 
development of colonic pseudo-obstruction is common in orthopedic procedures like total 
hip replacement (up to 1.5% of cases) and after total knee replacement (2.3%)[6]. The 
incidence is higher in hospitalized mentally-disabled patients reaching up to 18.5%[7]. 
Middle aged or elderly patients are commonly diagnosed with the disorder. The mean age 
of affected patients is 56.5 years for males and 59.9 years for females with a male to female 
ratio of 2:1.  
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3. Physiology of colonic motility 
The rate and extent of colonic motility is the accumulative result of neural siganls that cause 
intrinsic rhythmic contraction of the smooth muscles of the colon. Hyperpolarizing action 
potentials coincide with peaks of fluctuating potential difference across the cell membrane 
and result in contraction of the muscle[8]. The contraction of colonic smooth muscles is 
integrated by the myenteric plexus whose neurons have vesicles that release 
neurotransmitters, such as acetylcholine, noradrenaline, 5HT, peptides and purines[9]. The 
neurotransmitters produce spike potentials and rhythmic contractions that have a fixed 
maximum rate[10]. Nicotinic cholinergic fibers mediate rapid inhibitory reflex while 
purinergic fibers mediate excitatory descending pathway[11]. The resulting interdigestive 
myoelectric complexes [IMC] are propagated by the myenteric plexus at an interval of 15 to 
195 min., clearing the intestinal lumen[12]. The IMC are stimulated by the vagus nerve and 
motilin[13]. It is suppressed by ingestion of meals[14]. 
4. Pathophysiology 
Colonic pseudo-obstruction is a form of colonic dysmotility which is a final common 
pathway of various physiological, electrolyte and biochemical disturbances. There are 
primary and secondary pseudo-obstruction. Primary pseudo-obstruction is the familial 
visceral myopathy or hollow visceral myopathy syndrome, a diffuse motility disorder 
involving autonomous innervations of the intestinal wall. Secondary pseudo-obstruction is 
associated with other conditions such as the use of some medications, severe metabolic 
illness, diabetes, uremia, hyperparathyroidism etc. 
Colonic pseudo-obstruction can be neurogenic or myogenic in origin. It is the imbalance 
between sympathetic and parasympathetic innervations supplying colonic smooth muscle 
that causes pseudo-obstruction. This enteric nervous system forms a neural network 
residing in the submucosa and intermuscular layer of the colonic wall. Sympathetic nerve 
supply arises from lower thoracic and lumbar ganglia. The preganglionic nerves from these 
ganglia form a synapse in preaortic ganglia. The sympathetic nerves arising from these 
ganglia supply the colon. The parasympathetic nerve supply comes from the vagus nerve to 
the right half of colon up to splenic flexure, while the rest of colon is supplied by sacral 
nerve roots. Functional obstruction of the colon can be caused by increased sympathetic tone 
or decreased parasympathetic tone [15]. This autonomic dysfunction occurs mainly in 
postganglionic pathways and controls of the enteric nervous system. Two types of 
neurotransmitters are secreted by this system which are acetylcholine which increases 
intestinal secretions and motility and noradrenaline which decreases both intestinal 
secretions and motility. 
Some derangements also occur at the cellular and molecular levels and are thought to be 
part of the pathophysiology of this disorder. The interstitial cells of Cajal (ICC) are the 
pacemaker cells of the gastrointestinal tract and are essential for normal motility of the 
bowel. ICC form extensive network of electrically coupled cells some of which act as a 
pacemaker while others are involved in the relaxation of smooth muscles. ICC are either 
deranged or absent in patients of pseudo-obstruction. 
Nitric oxide may have a role in the development of pseudo-obstruction. It is involved in 
muscle relaxation and produced by the oxidation of L-arginine, mediated by increased 
nitrous oxide synthase activity and deficiency of c-kit cells in the intestine [16].  
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Migrating motor complexes (MMC) are waves of regular electromechanical activity 
observed in gastrointestinal smooth muscles and occur during fasting. In patients of 
pseudo-obstruction, there is uncoordinated intestinal contraction due to abnormal burst of 
MMC [17]. At the cellular level, there is deficiency of alpha actin in the inner circular layer of 
small bowel smooth muscle. Myosites are weak and undergo atrophy in myopathies and 
result in ineffective bowel propulsion. Anti-neuronal and anti-calcium channel antibodies 
cause enteral neuronal degeneration in patients who, in addition, have auto immune 
diseases and paraneoplastic conditions[18]. 
5. Etiology 
Multiple disorders are associated with colonic pseudo-obstruction (Table 1). However, there 
is no single factor responsible for the development of pseudo-obstruction. 
In a study that analyzed 400 cases of pseudo-obstruction, Vanek et al found the 
predisposing conditions associated with acute colonic pseudo-obstruction are: non-
operative trauma (11.3%), infection [pneumonia,sepsis] (10%), Cardiac [MI, heart failure] 
(10%), Obstetric and Gynecological disorders (9.8%), abdominal/pelvic surgery (9.3%), 
Neurologic (9.3%), Orthopedic Surgery (7.3%), miscellaneous medical conditions [metabolic, 
cancer, respiratory failure, renal failure] (32%), and miscellaneous surgical conditions 
[Urology, Thoracic, Neurosurgery] (11.8%)[39].  
 
Disorders associated with colonic pseudo-obstruction 
1.Surgical procedures- 
        1-Pelvic surgery. 
        2-Obstetric/gyne surgery. 
        3-Abdominal Surgery. 
        4-Hip Surgery. 
        5-Spinal surgery. 
        6-Thoracic/Cardiovascular Surgery. 
        7-Caesarean section. 
        8-Transplantation-Renal/Liver. 
 
2-Drugs- 
        1-Opiates. 
        2-Calcium channel blockers. 
        3-Antidepressants. 
        4-Antiparkinson drugs. 
        5-Anticholinergic. 
        6-Phenothiazines. 
        7-Laxative Abuse. 
        8-Amphetamine. 
        9-Vincristine. 
        10-Interleukins. 
        11-Clonidine. 
        12-Benzodiazepines. 
6-Malignancy- 
        1-Retroperitoneal cancer. 
        2-Leukemia. 
        3-Small cell lung cancer. 
        4-Pelvic radiotherapy. 
        5-Desseminated metastasis. 
7-Neurologic- 
        1-Demantia. 
        2-Parkinson’s disease. 
        3-Multiple sclerosis. 
        4-Cerebrovascular accident. 
        5-Nerve root compression. 
        6-Subarachnoid hemorrhage. 
8-Pulmonary- 
        1-Pneumonia. 
        2-Mechanical ventilation. 
        3-COPD. 
        4-Thoracic surgery. 
        5-Pulmonary thrombus. 
9-Cardiovascular – 
        1-Myocardial  infarction. 
        2-Congestive Heart failure. 
        3-Peripheral vascular disease. 
        4-Cardiovascular surgery. 
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3-Trauma- 
        1-Abdominal trauma. 
        2-Pelvic fracture. 
        3-Spinal trauma. 
        4-Femoral fracture. 
        5-Burns. 
4-Metabolic Disorders- 
        1-Electrolyte abnormalities. 
        2-Alcohalism. 
        3-Lead toxicity. 
        4-Diabetes Mellitus. 
        5-Uremia. 
        6-Hepatic failure. 
        7-Hypothyroidism. 
5-Infections- 
        1-Appendicitis. 
        2-Pancreatitis. 
        3-Cholecystitis. 
        4-Abdominal /pelvic abscess. 
        5-Sepsis. 
        6-Pseudomembranous colitis. 
        7-Herpes zoster.  
   
        5-Aortic aneurysm. 
10-Obstetric- 
        1-Post partum. 
        2-Caesarean section. 
Table 1. 
5.1 Etiological classification 
The disorders linked to the development of colonic pseudo-obstruction can be classified 
according to the pathophysiological derangement they ensue (Table 2).  
i. Dysfunction of nerve supply to the bowel 
The nerve supply of the bowel is affected in many diseases such as diabetes mellitus, 
amylodosis, and porphyria. While the motility of small bowel rarely gets affected, 
autonomic neuropathy commonly affects gastric emptying in diabetes. Colonic dilatation 
may be found in patients with severe diabetes [19]. In amyloidosis, amyloid deposition in 
nerves leads to abnormal response to cholinergic agents [20]. In secondary amyloidosis 
pseudo-obstruction occurs as a terminal manifestation [21]. Degenerative diseases of the 
myenteric plexus, such as Fabry’s disease, also are associated with pseudo-obstruction [22]. 
Intestinal motility is inhibited by some drugs and result in acute pseudo-obstruction. These 
drugs include atropine like drugs, clonidine, tricyclic antidepressants and 
vincristine[23,24,25,26]. Varicella infection is associated with damage of myenteric plexus [27]. 
Kawasaki disease and Chaga’s disease produce an abnormality of gut motility due to an 
inflammatory reaction in myenteric plexus [28]. 
ii. Dysfunction of colonic muscle 
Colonic smooth muscle dysfunction has been found in many cases of pseudo-obstruction. 
Visceral as well as skeletal muscle disorders have been linked with pseudo-obstruction of 
colon. Hereditary visceral myopathy is a degenerative disease of the longitudinal muscle 
layer which presents as an autosomal dominant disease[29] . Skeletal muscle disorders, such 
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as dystrophia myotonica and polymyositis, may also result in abnormal gastric and bowel 
motility[30]. 
 
 
1-Dysfunction of nerve of bowel- 
1-Metabolic- 
-  Diabetes Mellitus. 
- Amylodosis. 
- Porphyria. 
- Paraneoplastic syndrome. 
   
2-Toxins- 
- Drugs. 
- Insecticides. 
- Heavy metals. 
 
3-Inflammatory- 
- Varicella. 
- Chagas disease. 
- Kawasaki disease. 
 
2-Dysfunction of muscle of bowel- 
1-Familial visceral myopathy. 
2-Dystrophia myotonica. 
3-Polymyositis. 
3-Combined nerve and muscle dysfunction of bowel- 
1-Pregnancy. 
2-Hypoparathyroidism. 
3-Myxoedema. 
4-Pheochromocytoma. 
5-Trauma. 
6-Enteroglucagonoma. 
7-Jejuno-ileal bypass. 
4-Disorders of collagen and Interstitium of bowel- 
1-Radiation. 
2-Mesenteric Panniculitis. 
3-Scleroderma. 
4-Ehlers-Danlos syndrome. 
5-Sarcoidosis. 
6-Strongyloidosis.           
            
Table 2. Etiological classification 
iii. Combined nerve & muscles dysfunction of bowel 
Dysfunction of the intrinsic nervous system of bowel and muscular disorders together have 
been found in many cases of pseudo-obstruction of colon. There is infrequent IMC and slow 
intestinal transit during pregnancy. There are reports of pseudo-obstruction following 
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cesarean section[31]. Congenital hypoparathyroidism has been associated with pseudo-
obstruction[32]. Myxoedema also produces pseudo-obstruction[33]. Abdominal pain and 
vomiting is also associated with pseudo-obstruction caused by pheochromocytoma[34]. Blunt 
abdominal trauma is associated with pseudo-obstruction and often is linked with sepsis[35]. 
iv. Disorders of colonic collagen and interstitium 
Collagen metabolism is disturbed in colonic pseudo-obstruction. Irradiation to gut causes 
fibrosis which is more severe after pelvic irradiation[36]. Mesenteric panniculitis produces 
pseudo-obstruction by decreasing bowel wall compliance in addition to neural 
involvement[37]. Scleroderma produces excess collagen and causes pseudo-obstruction, 
volvulus, diverticulosis and perforation[38].   
6. Clinical features 
Patients are typically middle aged who are hospitalized for systemic disease or an unrelated 
surgical problem. The typical presentation is a picture of large intestinal obstruction. The 
disease can present as acute or chronic pseudo-obstruction. Acute cases present as mild or 
severe abdominal distension often causing diaphragmatic splinting and difficulty in 
breathing and usually occur in elderly patients following surgery. Chronic pseudo-
obstruction is associated with features of malabsorption and malnutrition.  
In acute pseudo-obstruction, marked abdominal distension is the most consistent clinical 
finding. Frequent other findings include abdominal pain, nausea, and vomiting. 
Constipation is a frequent symptom but 40% of patients have diarrhea. The pain is usually 
colicky but may be dull and constant. Fifty percent of patients show abdominal tenderness 
mainly in right iliac fossa. Bowel sounds may be hyperactive, high pitched or even normal. 
Ischemia and perforation are the most feared complications of acute colonic pseudo-
obstruction; spontaneous perforation has been reported in 3% to 15% of patients with a 
mortality rate of 50% or higher [39]. The rate of perforation and/or ischemia rapidly increases 
with a cecal diameters of >10 to 12 cm and also when the duration of distention exceeds 6 
days [40].. Fever may be present in some cases. The digital rectal examination typically 
reveals an empty rectum. Post operative pseudo-obstruction of the colon has been reported 
in many series following orthopedic, gynecological, urologic and lumbar spine 
surgery[41,42,43] 
7. Investigations  
Diagnosis depends on clinical presentation and the results of investigations. Investigations 
are needed to exclude mechanical cause of obstruction. Electrolyte disturbance is usually 
found in majority of patients with hypocalcemia, hyponatremia and hypokalemia being the 
most common laboratory finding. Leukocytosis is a frequent finding in cases of perforation 
or necrosis of the colonic wall. 
Plain abdominal X-rays (Figures 1, 2) is the initial radiological investigation for patients 
presenting with colonic obstruction. Distension of the colon, especially the caecum, is a 
common feature and its diameter measurement is essential (Figure 3). A caecal diameter of 
more than 12cm has been found to be associated more often with perforation, and at a 
diameter of 12 to 14cm the rate of perforation rose to 7% and climbed to 23% if caecal 
dilatation was more than 14cm [44]. Animal and retrospective data suggest a critical 
thresholds of 9 cm for the transverse colon and 12 cm for the cecum; however, many 
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patients present with dimensions greater than this without sequelae[45]. Colonic haustral and 
mucosal patterns are often maintained on X-rays. Transition from proximal dilated to 
decompressed colon is usually seen at the splenic flexure. Distension of colon follows 
Laplace’s law which states that pressure required to stretch the walls of hollow viscus varies 
inversely with its radius [46]. Laplace’s law is T=P*R/2 where T is wall tension, P is 
transmural pressure and R is radius of bowel. Cecum is more vulnerable to distension and 
perforation as it is the widest part of the colon. Serial plain abdominal x-rays are useful in 
cases of chronic pseudo-obstruction as they are less likely to perforate than acute 
obstruction. Serial x-rays are needed to monitor the progress of conservative therapy and to 
guide further management. 
 
 
Fig. 1. Distension of colon in pseudo-obstruction 
Low et al advised prone lateral view of the rectum to aid in diagnosis. He recommends 
placing the patient in the right lateral decubitus position for several minutes to allow 
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passage of gas into distal colon. This facilitates the gaseous filling of the rectum when the 
patient is positioned for a prone lateral view of the pelvis. He found 75% success rate in 
excluding mechanical obstruction when there was gaseous filling of rectum. 
 
 
Fig. 2. Transverse colon distension in pseudo-obstruction 
Contrast enema is very helpful when pseudo-obstruction of the colon is suspected. It is the 
investigation of choice to exclude mechanical obstruction and its sequel ,perforation[47]. The 
contrast material should be introduced under low pressure. There is no need for air to be 
introduced and the examination should be terminated when dilated colon is reached. 
Gastrografin is water soluble, clear and can be easily washed at the time of colonoscopy. 
Because it is hyperosmolar, it causes shift of fluids into lumen and, thus, has a low risk of 
contaminating the peritoneum when there is a perforation. Gastrografin enema confirms the 
diagnosis if there is absent, decreased or disorganized motility in any part of colon with 
decreased haustrations in the absence of any stricture [48].  
Computerized tomography [CT] is used to exclude mechanical causes of obstruction and, 
when intravenous and luminal contrasts are used, the radiologist can comment on the 
condition of the wall of the colon and luminal pathology. The presence of perforation can be 
diagnosed when there is extra-luminal leakage of the luminal contrast. CT imaging can also 
show the presence of other intra-abdominal or retroperitoneal and solid organs pathology. 
Colonoscopy is useful if done with caution as these patients may perforate. It can be both 
diagnostic and therapeutic as it can decompress the distended colon. Capsular endoscopy is 
not advised in pseudo-obstruction as it can be retained for long time[49]. 
Manometry and intestinal transit scintigraphy is used commonly in children with 
Hirschprung’s disease. Colonic dysmotility which may be segmental or global may cause 
massive colonic distension in these patients [50,51]. 
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Fig. 3. Distension of the right colon post femoral fracture   
8. Differential diagnosis 
Colonic pseudo-obstruction must be differentiated from mechanical causes of large bowel 
obstruction where there is a true physical cause of obstruction including colonic volvulus, 
strictures and tumors.  The differential diagnosis also includes various other causes of 
mechanical gastrointestinal obstruction as well as functional paralytic ileus and acute gastric 
distension. The clinical picture of colonic pseudo-obtruction may be confused with other 
causes of acute abdomen in patients who present late with symptoms and signs of 
perforation and peritonitis. 
8.1 Conservative management 
Patients of pseudo-obstruction are managed conservatively initially unless there are signs of 
mechanical obstruction or perforation. Initial management consists of correction of any 
precipitating factors that led to the development of pseudo-obstruction. Serial regular 
clinical examination should be performed for the development of abdominal tenderness or 
other signs of sepsis/peritonitis and abdominal x-rays should be repeated every twelve 
hours. Conservative measures can be used alone for 24-48 hours for patients without 
significant abdominal pain or signs of peritonitis and who have one or more potential 
underlying factors that are reversible. These patients are kept nil per orally with nasogastric 
tube suctioning for decompression. Rectal tube insertion has been used to aid in 
decompressing the distal colon. Body positioning (if feasible) often aid the spontaneous 
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evacuation of flatus. The patient is placed prone with the hips elevated on a pillow, in the 
knee-chest position with the hips high, or alternating right and left lateral decubitus 
position. The use of hyperbaric oxygenation may be effective in the management of chronic 
idiopathic intestinal pseudo-obstruction due to myopathy[52]. 
Sloyer et al. reportedsuccessful resolution in 92% of his patients by conservative 
management, with a mean cecal diameter 11.7 cm and a mean time to resolution of 1.6 days 
[44]. There was no perforation or death and most patients who responded to the conservative 
management did so within 3 to 6 days. They recommended invasive therapy only to those 
who do not respond to this treatment.  
Active intervention is indicated for patients who deteriorate despite conservative measures, 
those with clinical features of ischemia or perforation, and for patients with sepsis 
(significant pain, fever, leucocytosis), respiratory compromise, or hemodynamic instability. 
8.2 Medical treatment 
Neostigmine has been used widely for the treatment of colonic pseudo-obstruction. It is an 
acetylcholinestrase inhibitor which acts in reversible manner. It stimulates muscarinic 
receptors which in turn increases motor activity of colon and results in propulsion of feces in 
colon [53]. Its therapeutic effect is because of its parasympathomimetic effect. It increases 
parasympathetic activity which leads to hyperperistalsis. Neostigmine was first tried by 
Neely and Catchpole three decades ago in small bowel paralytic ileus[54]. Neostigmine is 
given intravenously and has a rapid onset [1-20 min] and short duration of action [1-2 
hrs][55]. Its half-life is 80 minutes.  
A randomized double blinded trial evaluated neostigmine in 11 patients with acute colonic 
pseudo-obstruction with a cecal diameter of >10 cm and no response to conservative 
therapy for 24 hrs [55]. The criteria for exclusion were- suspected ischemia or perforation, 
pregnancy, renal failure, arrhythmias and severe active bronchospasm. Patients were 
randomized to receive neostigmine 2 mg or saline by intravenous infusion over 3-5 minutes. 
The primary end point was a clinical response that prompts a decrease in abdominal 
distension which as determined by physical examination. Secondary end point was the 
change in abdominal girth and the change in colonic diameter on abdominal radiographs. 
Patients not responding within 3 hours were eligible for open label neostigmine. A clinical 
response was observed in 91% of patients randomized to receive neostigmine compared to 0 
receiving placebo. The median time to response was 4 minutes. The median reduction in 
cecal diameter [5 cm vs. 2 cm] and abdominal girth [7 cm vs. 1 cm] were significantly 
reduced in neostigmine group. Open label neostigmine was given in 8 patients who failed to 
respond to initial infusion [7 placebo, 1 neostigmine] and all had prompt decompression. 
The recurrence rate of colonic distension after neostigmine decompression was 11%. 
Common side effects were mild abdominal cramps and excessive salivation. Symptomatic 
bradycardia occurred in two patients who required atropine [55]. The side effects of 
neostigmine are due to excessive parasympathetic activity. 
Many other studies also have recommended neostigmine for the treatment of colonic 
pseudo-obstruction [56, 57, 58, 59]. Neostigmine administration should be done with caution. 
Patient requires admission to a high dependency unit or cardiac unit for the administration 
of neostigmine. The medication should be given while the patient is supine on the bed with 
continuous electro-cardiac monitoring in place. The physician should clinically assess the 
patient periodically and vital signs measurement should be done every 15-30 minutes. There 
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are some contraindication for neostigmine use, like mechanical bowel obstruction, suspected 
bowel ischemia or perforation, uncontrolled cardiac arrhythmias, renal insufficiency and 
severe bronchospasm.  
Neostigmine is a safe, effective and cheap medication in the management of colonic pseudo-
obstruction and the current available data recommend its use as the initial therapy of choice 
for patients not responding to conservative treatment. 
Erythromycin is another medication used in the management of colonic pseudo-obstruction. 
Erythromycin is a motilin receptor agonist that has been shown to decompress the bowel in 
a few case reports [60]. In one study erythromycin improved gastric emptying and intestinal 
transit measured by sulphamethizole methods and radio opaque markers, respectively [61]. 
Side effects include bloating, abdominal pain, nausea and vomiting. Repeated intravenous 
administration of erythromycin through a peripheral vein may cause phlebitis. 
Somatostatin analogue, Octreotide, is used in scleroderma and paraneoplastic syndromes. 
Its action is independent of motilin. Octreotide increases MMC especially in scleroderma 
patients by an unknown mechanism. Plasmapheresis may be useful in selected cases of 
paraneoplastic syndromes where pseudo-obstruction is associated with 
autoantibodies.Cisaperide and tegaseroid are also used in colonic pseudoobstruction[62,63]. 
Spinal anaesthesia has resolved some cases of intestinal pseudo-obstruction, which is due to 
blockade of sympathetic activity. 
Hyperbaric oxygen has been used in chronic idiopathic intestinal pseudo-obstruction due to 
myopathy although the exact mechanism of action is not known. 
Antibiotics can be used intermittently to suppress intestinal overgrowth and thus resolve 
pseudo-obstruction. Common antibiotics used are metronidazole, doxycycline, and 
ciprofloxacin. Table 3 summarizes the available medical treatment options.  
8.3 Colonoscopic treatment 
Many patients fail to respond to neostigmine and other conservative methods may need 
endoscopic decompression. The first use of colonoscopic decompression in cases of pseudo-
obstruction was done in 1977 by Kukora et al [64]. These patients have a risk of perforation 
following bowel ischemia. Colonoscopic decompression is done in these patients to prevent 
such complications. However, some precautions should be exercised when performing 
colonoscopy in these patients. Specifically, no oral laxatives or bowel preparation should be 
given and minimal air insufflation should be used during the procedure. There is no need to 
attempt to examine whole length of the colon. Suctioning the gas decompresses the colon 
and mucosal viability is assessed while slowly withdrawing the colonoscope. A per rectal 
tube for decompression should be left in the colon at the end of the procedure. 
The success of colonoscopic decompression has been reported in multiple studies. The initial 
extent bowel decompression is determined by a reduction in the cecal diameter by radiology. 
Less than half of the patients benefit from colonoscopic decompression without tube 
placement[65]. Placement of a tube following colonoscopy is strongly recommended as 
reported by many studies[66,67,68]. This seems to lower the recurrence rate although its value 
has not been evaluated in controlled trials. A perforation rate of 3% has been reported 
following colonic decompression by colonoscopy[69]. Despite of complications colonoscopic 
decompression in cases of colonic pseudo-obstruction is a useful tool [70]. Colonoscopic 
decompression of the colon is effective, causing decreased cecal diameter in 73% to 100%of 
cases[71]. The advantage of endoscopic decompression is that mortality rates for colonoscopic 
decompression were 1% to 5% compared with 12% to 20% for tube cecostomy[72]. However,  
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Table 3. Drugs used in the treatment of colonic pseudo-obstruction 
 
 
 
 
 
 
 
Table 4. Reports of success rate of various methods in pseudo-obstruction 
 
 
 
 
 
 
 
Table 5. Recurrence of pseudo-obstruction and morbidity associated with each method. 
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recurrence rates of 10% to 65%have been noted after initial success as documented by 
increased caecal diameter on radiography[73,74,75].  
Recently a randomized trial on the effect of oral Polyethylene Glycol (PEG) electrolyte 
balanced solution on the relapse of pseudo-obstruction after initial resolution with 
neostigmine or colonoscopic decompression showed sustained response rate and prevention 
of such episodes. Patients were randomized to receive PEG (29.5gm) or placebo and 
monitored for 7 days and it was found that 33% of recurrence rate in the patients who 
received placebo while none in PEG group. Therapy with PEG also resulted in significant 
increase in stool and flatus evacuations [76].  
8.4 Surgical decompression 
Surgery is reserved for those patients who do not respond to nonoperative management and 
those who present in sepsis, perforation or peritonitis [77]. Early recognition and prompt 
conservative management of pseudo-obstruction of the colon can minimize complications as 
well as the need for surgical intervention. Surgical options include percutaneous endoscopic 
colostomy, cecostomy and colectomy. Cecostomy can be done via the open or laparoscopic 
methods. Tube cecostomy is useful in acute colonic pseudo-obstruction as it achieves 
successful decompression with fewer complications. It is also useful in patients of chronic 
intestinal pseudo-obstruction [78].  
Colectomy is performed when there is perforation or gangrene of the colon. Right or left 
colectomy can be offered depending on the site of gangrene or perforation, often with 
colostomy or end ileostomy. There is a higher risk of abdominal compartment syndrome 
post abdominal surgery in these cases due to edema of abdominal viscera. Therefore, if 
primary closure of abdominal wall is difficult then temporary closure with delayed 
secondary permanent closure should be considered. In the post operative period, attention 
should be given to improve the splanchanic circulation as a previously dilated colon is more 
susceptible to perforation. Complications of surgical intervention include abdominal sepsis, 
anastomotic dehiscence, fistulas and abdominal compartment syndrome. Surgical site 
infections are also common with subsequent fascial dehiscence and incisional hernia. 
A chart summarizing the management of colonic pseudo-obstruction is shown in Figure 4. 
9. Prognosis and prevention 
Most of the patients stay hospitalized for less than a week. Increased in morbidity and 
mortality has been shown when surgical treatment was needed [79].  The mortality rate in 
medically treated patients is 14% and surgically treated patients is 30%, with a higher 
mortality in patients with cecal perforation or ischemia [80]. The reported incidence of cecal 
perforation is 3-40% with an associated mortality of 40-50%. A cecal diameter of greater than 
14 cm, a delay in colonic decompression and advanced age are the predictors of colonic 
perforation. 
Colonic pseudo-obstruction is a preventable disease in certain occasions, so emphasis 
should be on preventing this disease rather than on treatment, whenever possible. This can 
be done by early mobilization of hospitalized patients, prevention of constipation and the 
development of new pharmacologic agents which can resolve colonic inertia and help in 
propulsion of feces. 
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Fig. 4. Management flow chart. 
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